These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1079 related items for PubMed ID: 16317086

  • 1. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer.
    Shin VY, Wu WK, Chu KM, Wong HP, Lam EK, Tai EK, Koo MW, Cho CH.
    Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086
    [Abstract] [Full Text] [Related]

  • 2. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis.
    Yoon WH, Jung YJ, Kim TD, Li G, Park BJ, Kim JY, Lee YC, Kim JM, Park JI, Park HD, No ZS, Lim K, Hwang BD, Kim YS.
    Clin Cancer Res; 2004 Jul 01; 10(13):4517-26. PubMed ID: 15240544
    [Abstract] [Full Text] [Related]

  • 3. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW, Kim SJ, Choi HJ, Kim KJ, Kim MJ, Kim SH, Lee HJ, Ko JH, Lee YC, Suzuki A, Kim CH.
    Glycobiology; 2009 Mar 01; 19(3):229-39. PubMed ID: 18974200
    [Abstract] [Full Text] [Related]

  • 4. Antitumor activities of synthetic and natural stilbenes through antiangiogenic action.
    Kimura Y, Sumiyoshi M, Baba K.
    Cancer Sci; 2008 Oct 01; 99(10):2083-96. PubMed ID: 19016770
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of Kaposi's sarcoma in vivo by fenretinide.
    Ferrari N, Morini M, Pfeffer U, Minghelli S, Noonan DM, Albini A.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):6020-9. PubMed ID: 14676128
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI, Calvo A, Stafford J, Cheung M, Kumar R, Philp D, Kleinman HK, Green JE.
    Oncogene; 2005 Jan 27; 24(5):790-800. PubMed ID: 15592523
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor receptor-2-induced initial endothelial cell migration depends on the presence of the urokinase receptor.
    Prager GW, Breuss JM, Steurer S, Olcaydu D, Mihaly J, Brunner PM, Stockinger H, Binder BR.
    Circ Res; 2004 Jun 25; 94(12):1562-70. PubMed ID: 15131009
    [Abstract] [Full Text] [Related]

  • 8. Potential involvement of the cyclooxygenase-2 pathway in hepatocellular carcinoma-associated angiogenesis.
    Zhao QT, Yue SQ, Cui Z, Wang Q, Cui X, Zhai HH, Zhang LH, Dou KF.
    Life Sci; 2007 Jan 09; 80(5):484-92. PubMed ID: 17097688
    [Abstract] [Full Text] [Related]

  • 9. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI, Soroceanu L, Strongin AY.
    Cancer Res; 2002 Jan 15; 62(2):580-8. PubMed ID: 11809713
    [Abstract] [Full Text] [Related]

  • 10. Nicotine promotes colon tumor growth and angiogenesis through beta-adrenergic activation.
    Wong HP, Yu L, Lam EK, Tai EK, Wu WK, Cho CH.
    Toxicol Sci; 2007 Jun 15; 97(2):279-87. PubMed ID: 17369603
    [Abstract] [Full Text] [Related]

  • 11. Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803.
    Tian X, Song S, Wu J, Meng L, Dong Z, Shou C.
    Biochem Biophys Res Commun; 2001 Aug 24; 286(3):505-12. PubMed ID: 11511087
    [Abstract] [Full Text] [Related]

  • 12. [Expression of MMP-9 and MMP-9 mRNA in gastric carcinoma and its correlation with angiogenesis].
    Wang L, Zhang LH, Li YL, Li YL, Liu Z.
    Zhonghua Yi Xue Za Zhi; 2003 May 10; 83(9):782-6. PubMed ID: 12899759
    [Abstract] [Full Text] [Related]

  • 13. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
    Lee DH, Yang Y, Lee SJ, Kim KY, Koo TH, Shin SM, Song KS, Lee YH, Kim YJ, Lee JJ, Choi I, Lee JH.
    Cancer Res; 2003 Aug 01; 63(15):4648-55. PubMed ID: 12907645
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K, Brockmann MA, Eckerich C, Bohlen P, May C, Mangold U, Fillbrandt R, Westphal M.
    Clin Cancer Res; 2005 Jul 01; 11(13):4934-40. PubMed ID: 16000592
    [Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
    Kodama M, Kitadai Y, Tanaka M, Kuwai T, Tanaka S, Oue N, Yasui W, Chayama K.
    Clin Cancer Res; 2008 Nov 15; 14(22):7205-14. PubMed ID: 19010837
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F, Engst S, Yamaguchi K, Yu P, Won KA, Mock L, Lou T, Tan J, Li C, Tam D, Lougheed J, Yakes FM, Bentzien F, Xu W, Zaks T, Wooster R, Greshock J, Joly AH.
    Cancer Res; 2009 Oct 15; 69(20):8009-16. PubMed ID: 19808973
    [Abstract] [Full Text] [Related]

  • 17. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases.
    Etoh T, Inoue H, Tanaka S, Barnard GF, Kitano S, Mori M.
    Cancer Res; 2001 Mar 01; 61(5):2145-53. PubMed ID: 11280779
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy.
    Beebe JS, Jani JP, Knauth E, Goodwin P, Higdon C, Rossi AM, Emerson E, Finkelstein M, Floyd E, Harriman S, Atherton J, Hillerman S, Soderstrom C, Kou K, Gant T, Noe MC, Foster B, Rastinejad F, Marx MA, Schaeffer T, Whalen PM, Roberts WG.
    Cancer Res; 2003 Nov 01; 63(21):7301-9. PubMed ID: 14612527
    [Abstract] [Full Text] [Related]

  • 19. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH, Lee SH, Ahn EM, Lee YM.
    Carcinogenesis; 2009 Apr 01; 30(4):655-61. PubMed ID: 19228635
    [Abstract] [Full Text] [Related]

  • 20. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
    Fibbi G, Caldini R, Chevanne M, Pucci M, Schiavone N, Morbidelli L, Parenti A, Granger HJ, Del Rosso M, Ziche M.
    Lab Invest; 1998 Sep 01; 78(9):1109-19. PubMed ID: 9759655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.